ALKBH5 can reduce the stability of CK2α mRNA in a m6A-dependent manner, significantly inhibiting the proliferation of bladder cancer cells and sensitizing bladder cancer cells to cisplatin in vivo and in vitro [121]. Here, ALKBH5 is linked to urinary bladder cancer.